Clinical Trials Directory

Trials / Unknown

UnknownNCT00661648

Effect of an Artificial Pancreas in Patients Undergoing Pancreatic Resection

Prevention for Surgical Site Infection After Pancreatic Resection

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Kochi University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This study evaluated that strict control of perioperative blood glucose following pancreatic resection by using an artificial pancreas would improve postoperative surgical site infection.

Detailed description

This study recruited 50 patients undergoing elective pancreatic resection for pancreatic diseases. Perioperative blood glucose concentration was continuously monitored using an artificial pancreas system. We prospectively divided into two groups: one for whom glucose levels were controlled using a manual injection of insulin according to the commonly used sliding scale and another that received programmed infusion of insulin determined by the control algorithm of the artificial pancreas.

Conditions

Interventions

TypeNameDescription
DEVICEthe closed-loop STG-22 system (Nikkiso Inc, Tokyo, Japan)artificial pancreas

Timeline

Start date
2007-04-01
Primary completion
2009-04-01
Completion
2009-06-01
First posted
2008-04-18
Last updated
2009-01-29

Locations

1 site across 1 country: Japan

Source: ClinicalTrials.gov record NCT00661648. Inclusion in this directory is not an endorsement.

Effect of an Artificial Pancreas in Patients Undergoing Pancreatic Resection (NCT00661648) · Clinical Trials Directory